0000899243-19-024830.txt : 20191002 0000899243-19-024830.hdr.sgml : 20191002 20191002213856 ACCESSION NUMBER: 0000899243-19-024830 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191002 FILED AS OF DATE: 20191002 DATE AS OF CHANGE: 20191002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LeBel Carl CENTRAL INDEX KEY: 0001439275 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39062 FILM NUMBER: 191134178 MAIL ADDRESS: STREET 1: 23256 MARIPOSA DE ORO CITY: MALIBU STATE: CA ZIP: 90265 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Frequency Therapeutics, Inc. CENTRAL INDEX KEY: 0001703647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472324450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19 PRESIDENTIAL WAY, SUITE 203 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 781-315-4600 MAIL ADDRESS: STREET 1: 19 PRESIDENTIAL WAY, SUITE 203 CITY: WOBURN STATE: MA ZIP: 01801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-02 0 0001703647 Frequency Therapeutics, Inc. FREQ 0001439275 LeBel Carl C/O FREQUENCY THERAPEUTICS, INC., 19 PRESIDENTIAL WAY, 2ND FLOOR WOBURN MA 01801 0 1 0 0 Chief Development Officer Stock Option 3.37 2019-04-17 4 A 0 23555 0.00 A 2029-04-16 Common Stock 23555 23555 D Stock Option 3.37 2019-04-17 4 A 0 101930 0.00 A 2029-04-16 Common Stock 101930 101930 D Stock Option 14.00 2019-10-02 4 A 0 178937 0.00 A 2029-10-01 Common Stock 178937 178937 D This transaction is being reported pursuant to Rule 16a-2(a), and the securities covered by such transaction were previously included on the Reporting Person's Form 3. The option is fully vested. The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2019, and will be fully vested and exercisable on January 1, 2023. The option vests and becomes exercisable in equal monthly installments over a four year period commencing on November 2, 2019, and will be fully vested and exercisable on October 2, 2023. By: /s/ Michael D. Bookman, Attorney-in-Fact for Carl P. LeBel 2019-10-02